The global defibrillator market is estimated to grow $12.9 billion by 2019, at a CAGR of 6.9% from 2014 to 2019. Medtronic, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), Sorin Group (Italy), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Nihon Kohden Corporation (Japan), and HeartSine Technologies, Inc. (U.S.) are the key players operating in the global defibrillators market.
